Compare Jhonlin Agro Raya Tbk. (JARR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jhonlin Agro Raya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jhonlin Agro Raya Tbk. trades at Rp3,710 (market cap 34.25T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jhonlin Agro Raya Tbk. is far larger — about 328.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JARR | SCPI | |
|---|---|---|
Market Cap | 34.25T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jhonlin Agro Raya Tbk.
PT Jhonlin Agro Raya Tbk (the "Company") was established based on Notarial Deed No. 28 dated April 30, 2014 of Muhammad Hanafi, S.H. The Company commenced commercial operations in 2019.
Read more on JARR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
